检索

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)

Zhilyakova V.

(Rus)

Chronic lymphocytic leukemia/small lymphocytic lymphoma

Nikitin E., Bialik T., Zaritskii A., Iseber L., Kaplanov K., Lopatkina T., Lugovskaia S., Mukhortova O., Osmanov E., Poddubnaya I., Samoilova O., Stadnik E., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.

(Rus)

卷 26, 编号 1 (2024)

Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review

Sultanbaev A., Kolyadina I., Gilyazova I., Nasretdinov A., Musin S., Sultanbaeva N., Menshikov K.

(Rus)

The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review

Rykov I., Chubenko V.

(Rus)

Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib

Sekacheva M., Nuriev R., Rozhkov A., Semenkov A., Bagmet N., Boroda A.

(Rus)

卷 18, 编号 2 (2016)

Supportive therapy for ovarian cancer

Pokataev I., Tyulyandin S.

(Rus)

卷 17, 编号 4 (2015)

Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas

Borisov P., Orlova R., Shkolnik M., Karlov P.

Cabozantinib in the treatment of patients with advanced renal cell carcinoma

Volkova M., Turupaev K., Kalinin S.

(Rus)

New aspects of the first-line chemotherapy in colorectal cancer

Artamonova E.

Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review

Kolyadina I.

(Rus)

卷 21, 编号 1 (2019)

The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)

Morozov D., Kolyadina I., Poddubnaya I., Chumakov P., Ilinskaya G., Bokhian V., Sopova M.

(Rus)

卷 19, 编号 4 (2017)

Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0

Pavlikova O., Poddubnaya I., Kolyadina I., Abdullaev A., Komov D., Danzanova T., Sinyukova G., Kozlov N., Ganshina I., Zhukova L., Aliyeva G., Kerimov R., Gordeeva O.

(Rus)

First results of the Russian multicenter epidemiology project on the malignant gliomas

Smolin A., Bekyashev A., Kobyakov G., Sharabura T., Mufazalov F., Kanischeva N., Bumagina V.

Current approach to adjuvant therapy for breast cancer (a review)

Conte P., Guarneri V.

Radiation injuries of organs and tissues: mechanisms of occurrence, methods of prevention and treatment: A review

Balaeva D., Romanov D., Trofimova O., Gadzhibabaeva Z., Gorchak Y., Gariaev G.

(Rus)

Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review

Kolyadina I.

(Rus)

Bevacizumab in advanced ovarian cancer: when, what for and why?

Tjulandina A.

卷 26, 编号 2 (2024)

Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review

Dinikina Y., Zheludkova O., Ryzhova M., Olhova L., Korneev D., Belogurova M.

(Rus)

Novel therapeutic strategies for patients with metastatic triple-negative breast cancer

Ganshina I., Gordeeva O., Manukian M.

(Rus)

Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0

Manikhas A., Grinev I., Oganesian A., Chikrizov S., Manikhas G.

(Rus)

卷 18, 编号 1 (2016)

Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy

Kolyadina I., Poddubnaya I., Pavlikova O., Komov D.

(Rus)

卷 26, 编号 2 (2024)

Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data

Savchenko I., Stilidi I., Dzhanyan I., Antonova E., Polyakov A., Egorova A., Chulkova S., Breder V.

(Rus)

卷 24, 编号 3 (2022)

Triple-negative breast cancer: new options for systemic targeted therapy. A review

Andreev D., Zavyalov A.

(Rus)

卷 22, 编号 2 (2020)

Adjuvant targeted therapy for non-small cell lung cancer

Laktionov K., Kazakov A., Gordiev M., Kononets P., Akhmedov B., Maevskaia J.

(Rus)

Modern technology of radiation therapy: IMRT, VMAT using simultanting integrated boost (SIB) in the complex treatment of squamous cell carcinoma of the anal canal

Tkachev S., Glebovskaya V., Rasulov A., Tsariuk V., Aliev V., Vodyanik V.

卷 26, 编号 1 (2024)

Isolated metastasis to the scalp in occult breast cancer: a clinical case

Ognerubov N., Sergeev R., Hizhnyak A., Ognerubova M., Dzhabrailov M.

(Rus)

卷 24, 编号 3 (2022)

CAR NK-сells for the treatment of hematological malignancies: A review

Gribkova I.

(Rus)

卷 26, 编号 1 (2024)

Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study

Sultanbaev A., Kolyadina I., Menshikov K., Musin S., Nasretdinov A., Sultanbaeva N., Rakhimov R., Lipatov D., Menshikova I., Izmailov A., Lipatova E.

(Rus)

卷 24, 编号 1 (2022)

Nutritional support in the perioperative period of treatment of cancer patients: Retrospective cohort study

Gameeva E., Stepanovna A., Khoronenko V., Gridnev O., Sviridov S., Shestopalov A.

(Rus)

Can musical interventions benefit patients with cancer?

Razumovskaya E.

(Rus)

The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021

Editorial B.

(Rus)

卷 23, 编号 3 (2021)

Malignant neoplasms associated with HIV infection. Problems and solutions (problem outline)

Kaprin A., Voronin E., Rassokhin V., Rozenberg V., Nekrasova A., Falaleeva N., Ivanov S., Grivtsova L.

(Rus)

Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice

Kolyadina I., Abidova N., Akopyan A., Antonova G., Arapova O., Bobrova E., Bolotina L., Valiakhmetova C., Vasilevskaya A., Vladimirova L., Volkonskiy M., Ganshina I., Gudkova I., Dergunov A., Evstigneeva I., Egurenkova V., Emshanov A., Zhukova L., Zueva E., Karabina E., Kolokolov J., Kuzmicheva S., Kuchevskaya O., Luev I., Maistrenko K., Markizova E., Marfutov V., Medvedev S., Merzlikina Y., Nersesova T., Ovchinnikova E., Orlova S., Samaneva N., Stativko O., Storozhakova A., Stroyakovskiy D., Sultanbaev A., Tekeeva A., Fadeeva N., Fedorova A., Shalaeva O., Shangina I., Shirokova O., Shumskikh A., Yakubova M.

(Rus)

(Eng)

卷 21, 编号 4 (2019)

The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution

Poddubnaya I., Bialik T., Glonina N., Kalashnikova O., Kaplanov K., Lapin V., Medvedeva N., Mikhailova N., Moiseeva T., Nikitin E., Pospelova T., Stadnik E.

(Rus)

卷 19, 编号 4 (2017)

Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case

Kolyadina I., Ganshina I., Zhukova L., Abdullaev A., Andreeva Y., Danzanova T., Sinyukova G., Komov D., Kozlov N., Filonenko D., Gordeeva O., Lubennikova E.

(Rus)

Radiation treatment of the primary vulvar Pagetʼs disease: case report

Razumova E., Kizhaev Y., Ukolova E.

HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment

Besova N.

New horizons in skin malignancies treatment

Gamaunov S.

Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies

Kit O., Vladimirova L., Sholokhova E.

Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]

Yudina E.

(Rus)

The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases

Polyanskaya E., Fedyanin M.

(Rus)

Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report

Protasova A., Strakh L., Lando E., Sidorkina E.

(Rus)

Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)

Ziganshin A.

(Rus)

Prospects for the development of adjuvant therapy for non-small cell lung cancer

Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.

(Rus)

卷 21, 编号 4 (2019)

Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children

Shervashidze M., Valiev T., Batmanova N., Tupitsyn N., Serebryakova I.

(Rus)

Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience

Valiev T., Levashov A., Batmanova N., Senzhapova E., Turupaev K., Tomchik U., Aleskerova G.

(Rus)

卷 18, 编号 4 (2016)

Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma

Ignatova A.

卷 17, 编号 4 (2015)

Neoadjuvant systemic therapy of HER2-positive breast cancer

Frolova M.

Keratoacanthoma: possible management approaches. Case reports

Teterin K., Kizhaev Y., Bolotova N.

The role of cytokines in the chemotherapy of malignant tumors:the practice of cytokines Refnot® and Ingaron® administration in advanced cancer with multiple metastases

Bryuzgin V., Platinskij L.

Combined and complex treatment options for patients with operable rectal cancer

Barsukov Y., Tkachev S., Mamedli Z., Kuzmichev D., Aliev В., Kim D.

Dermatological toxicity in the treatment of malignant tumors in children: A review

Belysheva T., Shatokhina E., Komarova A.

(Rus)

The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial

Volchegorskii I., Vazhenin A., Alekseeva A.

(Rus)

The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem The results of the project with the discussion concerning the possibility of optimization approaches for the therapy

Editorial B.

(Rus)

Pharmacogenetic markers of chemotherapy toxicity in gastrointestinal tumors: a preliminary analysis

Fedorinov D., Geidarov R., Shashkov I., Mikhailovich V., Lyadova M., Pokataev I., Lyadov V.

(Rus)

Vulvar cancer: brain metastases. Clinical observation

Ognerubov N., Antipova T., Kamneva N.

(Rus)

卷 18, 编号 2 (2016)

Prognostic factors in patients with disseminated gastrointestinal stromal tumors

Arkhiri P., Stilidi I., Poddubnaya I., Nered S., Nikulin M., Abu-Khaydar O.

(Rus)

卷 17, 编号 4 (2015)

Modern possibilities of targeted therapy in metastatic colorectal cancer

Gorbunova V.

Modern options in personalized therapy of metastatic cutaneous melanoma

Protsenko S., Novik A., Akhaeva Z., Zhabina A., Imyanitov E., Semenova A.

Is maintenance therapy following previous treatment better than observation or placebo for treating chronic lymphocytic leukaemia in adults? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)

The role of tamoxifen in the therapy of metastatic ovarian cancer

Davidenko I., Kazantseva M., Porhanova N., Ohanyan M.

卷 26, 编号 2 (2024)

Editorial B.

(Rus)

Modern strategy of treatment of patients with retroperitoneal sarcomas: A review

Stilidi I., Nikulin M., Kalinin O., Abgiarian M., Vashakmadze L., Fainshtein I., Arkhiri P., Salimova A.

(Rus)

Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON

Tryakin A., Fedyanin M., Moiseenko F., Mironov O., Stroyakovskiy D., Sokolov N., Orlova S., Mantsyrev E., Sultanbaev A., Teterich A., Babina K., Yukalchuk D., Borzyanitsa S., Isyangulova A., Saidullaeva A., Chernova Y., Bobrova E., Fadeeva N., Chobanu D.

(Rus)

Biological features of ductal carcinoma in situ: clinical role and basis for treatment individualization

Kolyadina I., Butrimova A., Poddubnaya I., Kоmetova V., Rodionov V.

(Rus)

The role of radiation therapy in the treatment of patients with pleural mesothelioma

Borisova T., Tkachev S., Ivanov S., Alieva S., Trofimova O., Glebovskaya V., Breder V., Laktionov K., Marinov D., Abdullaev A.

(Rus)

Opportunities for metastatic triple negative breast cancer therapy

Ganshina I., Gordeeva O., Manukyan M.

(Rus)

卷 21, 编号 2 (2019)

Unresectable hepatocellular carcinoma: new opportunities and prospects for therapy

Abdurakhmanov D., Breder V., Bolotina L., Kosyrev V., Medvedeva B., Petkau V.

(Rus)

Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal

Glebovskaya V., Tkachev S., Ivanov S., Nazarenko A., Rasulov A., Gordeev S., Bulychkin P., Besova N., Barsukov U., Trofimova O., Borisova T., Timoshkina E.

(Rus)

卷 18, 编号 2 (2016)

The role of regorafenib in the treatment of metastatic colorectal cancer

Tryakin A.

(Rus)

卷 17, 编号 2 (2015)

The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients

Frank G., Ilatovskaia M., Andreeva I., Zavalishina L.

Clinical cases of treatment of hepatocellular carcinoma

Lazarev S., Mamontov K., Manihas G., Antimonik N.

卷 15, 编号 4 (2013)

Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney

Klimenko A., Ivanov S.

Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice

Poddubnaya I., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.

How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review

Zhukova L., Bordin D., Dubtsova E., Ilin M., Kiriukova M., Feoktistova P., Egorov V.

(Rus)

Combination of encorafenib and binimetinib in the treatment of patients with BRAF-mutated advanced melanoma. Case report

Orlova K., Petenko N., Garanina N., Demidov L.

(Rus)

卷 24, 编号 1 (2022)

Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)

Staroverova T.

(Rus)

Endoscopic esophageal stenting in combination with chemoradiation therapy: A review

Ivanov A., Popov V., Burmistrov M.

(Rus)

Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic

Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.

(Rus)

卷 22, 编号 2 (2020)

First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice

Babicheva L., Poddubnaya I.

(Rus)

卷 20, 编号 4 (2018)

Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy?

Dadyev I., Davydov M., Shogenov M., Abdullaev A., Ibraev M., Filatov A.

(Rus)

卷 17, 编号 1 (2015)

The role of targeted therapy in the treatment of advanced hepatocellular carcinoma

Shakhnovich E., Kerbikov O., Kulaga E.

Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I?

Kolyadina I., Poddubnaya I., Trofimova O., Frank G., Karseladze A., Komov D.

Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives

Alekseev B., Nyushko K., Kalpinskiy A., Kaprin A.

Role of vemurafenib in the treatment of disseminated skin melanoma

Demidov L., Utyashev I., Kharkevich G.

Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review

Dinikina Y., Zheludkova O., Belogurova M., Spelnikov D., Osipov N., Nikitina I.

(Rus)

Creating a story on the pages of a book about diffuse B-large cell lymphoma

Editorial B.

(Rus)

卷 23, 编号 3 (2021)

Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation

Gorenkova L., Belousova I., Kravchenko S., Kovrigina A., Sidorova Y., Ryzhikova N., Lepik E., Shneyder T.

(Rus)

Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review

Menshikov K., Sultanbaev A., Akhmetgareeva K., Lipatov D.

(Rus)

Multiple myeloma

Mendeleeva L., Votiakova O., Rekhtina I., Osmanov E., Poddubnaya I., Grivtsova L., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.

(Rus)

卷 20, 编号 2 (2018)

The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan

Berdimyradova M., Khadjiev S., Khommadova D., Polatova G., Kakajanova A., Batyrov C., Penayev D., Agayeva B., Annaberdiyeva G.

(Rus)

The treatment of patients with advanced lung cancer associated with EGFR mutation

Bolotina L.

(Rus)

卷 18, 编号 1 (2016)

The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options

Artamonova E., Manzyuk L.

(Rus)

卷 17, 编号 1 (2015)

Radiation-induced lung injury in breast cancer patients after breast conservation therapy

Trofimova O., Tkachev S., Ivanov S., Utkina V., Cheban O., Glebovskaya V.

Personalized approach to HER2-positive advanced breast cancertherapy

Stenina M.

Surgical stading local – cervical cancer incidence

Kargopolova M., Maximov S., Berlev I., Boyarkina M., Meshkova I., Khadzhimba A., Novikov S., Krzhivitsky P., Ponomareva O., Urmancheeva A., Ivanzov A., Guseynov K., Vishinskaya E., Matveeva N.

卷 25, 编号 3 (2023)

Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]

Melnikov V.

(Rus)

Own experience in the treatment of primary refractory Hodgkin's lymphoma. Case report

Gushchina E., Vernyuk M., Chervontseva A., Cherkashina I., Khayrullina L., Lunin V., Fedenko A.

(Rus)

卷 23, 编号 3 (2021)

ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia

Bialik T., Vorob'ev V., Ionin V., Ysebaert L., Kaplanov K., Mendeleeva L., Nikitin E., Ptushkin V., Samoilova O., Stadnik E.

(Rus)

Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma

Ignatova A.

(Rus)

The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor

Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up

Ognerubov N., Antipova T., Gumareva G.

(Rus)

卷 22, 编号 2 (2020)

Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience

Kolyadina I., Ganshina I., Kuzmicheva S., Tekeeva A., Kolokolov J., Volkonskii M., Poddubnaya I.

(Rus)

(Eng)

卷 20, 编号 1 (2018)

Dermatomyositis and polymyositis in breast cancer patients: a case reports

Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.

(Rus)

卷 19, 编号 1 (2017)

Ryazhenov V.

(Rus)

卷 17, 编号 3 (2015)

Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer

Knyazev R., Poddubnaya I., Barinov V., Bokin I.

Vulvar Langerhans cell histiocytosis: case report

Poddubnaya I., Razumova E., Kizhaev Y., Ukolova E., Teterin K.

Radiation therapy as an independent method of treatment in case of carcinoma of floor of mouth

Garbuzov M.

Angiogenesis as a target for cancer therapy

Imyanitov E.

Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases

Sekacheva M., Bagmet N., Polishchuk L., Glazova O., Zaklyazminskaya E., Skripenko O.

卷 25, 编号 3 (2023)

Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis

Lyadova M., Fedorinov D., Kuzmina E., Antonova T., Sokolskaya V.

(Rus)

Prospects for the treatment of neurofibromatosis type 1: A review

Mustafin R.

(Rus)

Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer

Radzhabova Z., Kotov M., Girshovich M., Ponomareva O., Tkachenko E., Mitrofanov A., Radzhabova M., Levchenko E.

(Rus)

Antiangiogenic therapy for breast cancer with triple negative phenotype

Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.

(Rus)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma

Bolotina L.

(Rus)

卷 22, 编号 1 (2020)

ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution

Poddubnaya I., Al-Radi L., Byalik T., Kaplanov K., Molostvova V., Nikitin E., Pospelova T., Ptushkin V., Samoilova O., Stadnik E., Tumyan G.

(Rus)

卷 19, 编号 4 (2017)

Clinical cases of the treatment of metastatic colorectal cancer in Russia

Goldberg V., Hasanova A., Shkuratova V., Belevich Y., Popova N., Simolina E., Vysockaya V., Dudnikova E., Kravchuk T., Minnabetdinova R., Nekrasova O.

(Rus)

卷 19, 编号 1 (2017)

Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer

Pavlikova O., Kolyadina I., Komov D., Vishnevskaya Y., Poddubnaya I.

(Rus)

卷 17, 编号 3 (2015)

Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer

Bazaeva I., Gorbounova V., Kravets O., Khokhlova S., Romanova E.

卷 17, 编号 1 (2015)

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer

Semiglazova T., Dashyan G., Semiglazov V., Zhabina A., Osipov M., Kotova Z., Klimenko V., Krivorotko P., Semiglazov V.

The effect of combinated treatment of a metastatic HER2-positive stomach cancer

Khvastunov R., Nenarokomov A., Tolstopiatov S., Babina K.

The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program

Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.